SD BioSensor, Inc (137310.KS)
KRW 9500.0
(1.06%)
KRW 9500.0
(1.06%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 957.28 Billion KRW | 203.76% |
| 2022 | 315.14 Billion KRW | -60.69% |
| 2021 | 801.72 Billion KRW | 13.87% |
| 2020 | 704.09 Billion KRW | 2113.84% |
| 2019 | 31.8 Billion KRW | 45.5% |
| 2018 | 21.85 Billion KRW | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q2 | 876.33 Billion KRW | 2.81% |
| 2024 Q1 | 852.41 Billion KRW | -10.95% |
| 2023 Q1 | 1427.85 Billion KRW | 353.08% |
| 2023 FY | 957.28 Billion KRW | 203.76% |
| 2023 Q3 | 904.2 Billion KRW | -28.72% |
| 2023 Q4 | 957.28 Billion KRW | 5.87% |
| 2023 Q2 | 1268.52 Billion KRW | -11.16% |
| 2022 Q3 | 516.91 Billion KRW | -30.81% |
| 2022 Q2 | 747.13 Billion KRW | -41.07% |
| 2022 Q1 | 1267.76 Billion KRW | 58.13% |
| 2022 FY | 315.14 Billion KRW | -60.69% |
| 2022 Q4 | 315.14 Billion KRW | -39.03% |
| 2021 FY | 801.72 Billion KRW | 13.87% |
| 2021 Q4 | 801.72 Billion KRW | 30.22% |
| 2021 Q3 | 615.66 Billion KRW | 3.06% |
| 2021 Q2 | 597.4 Billion KRW | -12.27% |
| 2021 Q1 | 680.96 Billion KRW | -3.29% |
| 2020 Q4 | 704.09 Billion KRW | 0.0% |
| 2020 FY | 704.09 Billion KRW | 2113.84% |
| 2019 FY | 31.8 Billion KRW | 45.5% |
| 2018 FY | 21.85 Billion KRW | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| Dentium CO., LTD | 309.89 Billion KRW | -208.904% |